Correlation Between CSL and Telix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both CSL and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on CSL and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Telix Pharmaceuticals.
Diversification Opportunities for CSL and Telix Pharmaceuticals
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between CSL and Telix is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding CSL and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of CSL i.e., CSL and Telix Pharmaceuticals go up and down completely randomly.
Pair Corralation between CSL and Telix Pharmaceuticals
Assuming the 90 days horizon CSL is expected to under-perform the Telix Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, CSL is 2.44 times less risky than Telix Pharmaceuticals. The pink sheet trades about -0.22 of its potential returns per unit of risk. The Telix Pharmaceuticals Limited is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,400 in Telix Pharmaceuticals Limited on August 29, 2024 and sell it today you would earn a total of 56.00 from holding Telix Pharmaceuticals Limited or generate 4.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CSL vs. Telix Pharmaceuticals Limited
Performance |
| Timeline |
| CSL |
| Telix Pharmaceuticals |
CSL and Telix Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CSL and Telix Pharmaceuticals
The main advantage of trading using opposite CSL and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.The idea behind CSL and Telix Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Telix Pharmaceuticals vs. Genscript Biotech | Telix Pharmaceuticals vs. Keros Therapeutics | Telix Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Telix Pharmaceuticals vs. Innovent Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |